Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering ...

Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...

The network currently generates approximately €10 million (approximately $11.5 million based on the prevailing EUR/USD exchange rate) in annual gross revenue and serves a broad base of pharmacy ...

Medical cannabis leader Bioxyne predicts the local market will hit $1 billion – but suppliers need to shed the 'rasta' labelling.

We’re running million-dollar production lines on ancient software because no one wants to risk a shutdown, but ignoring that "time bomb" is becoming way too risky.

Consider it your chance to have the first look at – and the last word on – all of Vogue’s content. We, and our Our editors work with affiliates when we select some or all of the products featured. We ...

Canada’s obligation to Veterans is reflected not only in words, but in the careful design of the programs that support them. A reimbursement model that accurately reflects the medical market would ...

GenThera, Inc., a radiopharmaceutical company, announces partnership with Alpha Nuclide Co, LTD to secure scalable ...

(MENAFN- GlobeNewsWire - Nasdaq) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media ...

AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar ...